Jaffer A. Ajani, MD, an internationally recognized expert on gastrointestinal cancers, is Professor of Gastrointestinal Medical Oncology at MD Anderson Cancer Center and Chair of the NCCN Clinical Practice Guidelines in Oncology for Esophageal and Gastric Cancers. He has participated over the past 20 years in numerous trials using innovative combined modality therapies for localized gastric and esophageal cancers, and some of his work has led to the development of strategies of preoperative therapy for resectable upper gastrointestinal cancers.
His current research focus is on developing programs to research the molecular markers for progression of Barrett’s metaplasia to adenocarcinoma. These research efforts involve multi-institutional collaboration with investigators at the University of Chicago, University of Pennsylvania, Mayo Clinic, and Yonsei University, in Seoul, Korea.
In addition to his work with NCCN, Dr. Ajani participates actively in the International Society of Gastrointestinal Oncology is the editor of the Society’s journal, Gastrointestinal Oncology Research.
The ideas and viewpoints expressed in this editorial are those of the author and do not necessarily represent any policy, position, or program of NCCN.
ShiozakiH, SudoK, XiaoL. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology2014;86:336–339.
ShiozakiHSudoKXiaoL. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology2014;86:336–339.